# CAR-T Cell Therapy for ALL

> **NCT07695012** · EARLY_PHASE1 · RECRUITING · sponsor: **Dr. Zaineb Akram** · enrollment: 10 (estimated)

## Conditions studied

- Relapsed Acute Lymphoblastic Leukemia (ALL)

## Interventions

- **BIOLOGICAL:** CAR-T cell infusion

## Key facts

- **NCT ID:** NCT07695012
- **Lead sponsor:** Dr. Zaineb Akram
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695012, "CAR-T Cell Therapy for ALL". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*